| 产品详情 |
| Edit |   |
|---|
| Product Name | UBP 310 |
|---|
| Description | GluK1 (formerly GLUK5) kainate receptor antagonist (IC50 = 130 nM); also blocks recombinant homomeric GluK3 (forrmerly GLUK7) receptors. Displays 12,700-fold selectivity for GluK1 (formerly GLUK5) over GluK2 (formerly GLUK6). Exhibits no activity at mGlu group I or NMDA receptors at concentrations of up to 10 μM. Apparent KD value is 18 ± 4 nM for depression of kainate responses on the dorsal root. Please refer to IUPHAR Guide to Pharmacology for the most recent naming conventions. Purity 98%. MW (observed): 353.35 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-thiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione |
|---|
| Gene, Accession, CAS # | CAS: 902464-46-4 |
|---|
| Catalog # | 3621/50 |
|---|
| Price | |
|---|
| Order / More Info | UBP 310 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 22205648, 24801624 |
|---|
| 产品资料 |
|
|